References
- Sutherland SK, Tibballs J. Genus Pseudechis, Black Snakes. Australian Animal Toxins. Melbourne: Oxford University Press; 2001:137–159.
- Broad AJ, Sutherland SK, Coulter AR. The lethality in mice of dangerous Australian and other snake venom. Toxicon 1979; 17:661–664.
- Chen SZ, Gopalakrishnakone P, Gwee MC. Pharmacological effects and pathological changes induced by the venom of Pseudechis australis in isolated skeletal muscle preparations. Toxicon 1994; 32: 303–315.
- Ponraj D, Gopalakrishnakone P. Morphological changes induced by a generalized myotoxin (myoglobinuria-inducing toxin) from the venom of Pseudechis australis (king brown snake) in skeletal muscle and kidney of mice. Toxicon 1995; 33:1453–1467.
- Lane J, O’Leary MA, Isbister GK. Coagulant effects of black snake (Pseudechis spp.) venoms and in vitro efficacy of commercial antivenom. Toxicon 2011; 58:239–246.
- Dambisya YM, Lee TL, Gopalakrishnakone P. Anticoagulant effects of Pseudechis australis (Australian king brown snake) venom on human blood: a computerized thromboelastography study. Toxicon 1995; 33:1378–1382.
- Takasaki C, Tamiya N. Isolation and amino acid sequence of a short-chain neurotoxin from an Australian elapid snake, Pseudechis australis. Biochem J 1985; 232:367–371.
- St Pierre L, Masci PP, Filippovich I, Sorokina N, Marsh N, Miller DJ, Lavin MF. Comparative analysis of prothrombin activators from the venom of Australian elapids. MolBiolEvol 2005; 22:1853–1864.
- Sharp PJ, Berry SL, Spence I, Howden ME. A basic phospholipase A from the venom of the Australian king brown snake (Pseudechis australis) showing diverse activities against membranes. Comp Biochem Physiol B 1989; 92:501–508.
- Fatehi M, Rowan EG, Harvey AL. An electrophysiological study on the effects of Pa-1G (a phospholipase A(2)) from the venom of king brown snake, Pseudechis australis, on neuromuscular function. Toxicon 2002; 40:69–75.
- Rowlands JB, Mastaglia FL, Kakulas BA, Hainsworth D. Clinical and pathological aspects of a fatal case of mulga (Pseudechis australis) snakebite. Med J Aust 1969; 1:226–230.
- Campbell CH. Myotoxic paralysis and hemolytic anemia due to king brown snake bite. Aust N Z J Med 1984; 14:169.
- Isbister GK, Currie BJ. Suspected snakebite: one year prospective study of emergency department presentations. EmergMed(Fremantle). 2003; 15:160–169.
- Currie BJ. Snakebite in tropical Australia: a prospective study in the “Top End” of the Northern Territory. Med J Aust 2004; 181:693–697.
- White J. A review of 105 cases of suspected snakebite in South Australia. In: Gopalakrishnakone P, Tan C, eds. Progress in Venom and Toxin Research. Singapore: National University of Singapore; 1987:15–19.
- Churchman A, O’Leary MA, Buckley NA, Page CB, Tankel A, Gavaghan C, et al. Clinical effects of red-bellied black snake (Pseudechis porphyriacus) envenoming and correlation with venom concentrations: Australian Snakebite Project (ASP-11). Med J Aust 2010; 193:696–700.
- Ramasamy S, Isbister GK, Hodgson WC. The efficacy of two antivenoms against the in vitro myotoxic effects of black snake (Pseudechis) venoms in the chick biventer cervicis nerve-muscle preparation. Toxicon 2004; 44:837–845.
- Johnston CI, O’Leary MA, Brown SG, Currie BJ, Halkidis L, Whitaker R, et al. Death adder envenoming causes neurotoxicity not reversed by antivenom – Australian snakebite project (ASP-16). PLoS Negl Trop Dis 2012; 6:e1841.
- Allen GE, Brown SG, Buckley NA, O’Leary MA, Page CB, Currie BJ, et al. Clinical effects and antivenom dosing in brown snake (Pseudonaja spp.) envenoming – Australian snakebite project (ASP-14). PLoS One 2012; 7:e53188.
- Isbister GK, White J, Currie BJ, et al. Clinical effects and treatment of envenoming by Hoplocephalus spp. snakes in Australia: Australian Snakebite Project (ASP-12). Toxicon 2011; 58:634–640.
- Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF Jr, Bock SA, Branum A, et al. Second symposium on the definition and management of anaphylaxis: summary report–Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol. 2006; 117:391–397.
- Brown SG. Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol 2004; 114:371–376.
- Kulawickrama S, O’Leary MA, Hodgson WC, Brown SG, Jacoby T, Davern K, Isbister GK. Development of a sensitive enzyme immunoassay for measuring taipan venom in serum. Toxicon 2010; 55:1510–1518.
- Isbister GK, Hooper MR, Dowsett R, Maw G, Murray L, White J. Collett's snake (Pseudechis colletti) envenoming in snake handlers. QJM 2006; 99:109–115.
- Isbister GK. Snakebite doesn't cause disseminated intravascular coagulation: coagulopathy and thrombotic microangiopathy in snake envenoming. Semin Thromb Hemost 2010; 36:444–451.
- Bailey PM, Bakker AJ, Seymour JE, Wilce JA. A functional comparison of the venom of three Australian jellyfish–Chironex fleckeri, Chiropsalmus sp., and Carybdea xaymacana–on cytosolic Ca2+, haemolysis and Artemia sp. lethality. Toxicon 2005; 45:233–242.
- Isbister JP. Blood volume, Haematocrit and Hemorheology: The interrelationships. Clin Hemorheol 1994; 14:15.
- Isbister GK, O’Leary MA, Elliott M, Brown SG. Tiger snake (Notechis spp) envenoming: Australian Snakebite Project (ASP-13). Med J Aust. 2012; 197:173–177.
- O’Leary MA, Isbister GK. Commercial monovalent antivenoms in Australia are polyvalent. Toxicon 2009; 54:192–195.
- Isbister GK, Brown SGA. Bites in Australian snake handlers – Australian snakebite project (ASP-15). QJM 2012; (in press).
- Isbister GK, Brown SG, MacDonald E, White J, Currie BJ; Australian Snakebite Project Investigators. Current use of Australian snake antivenoms and frequency of immediate-type hypersensitivity reactions and anaphylaxis. Med J Aust 2008; 188:473–476.